×
About 118 results

ALLMedicine™ Geriatric Psychiatry Center

Research & Reviews  24 results

A Survey of Geriatric Psychiatry Fellows and Program Directors: Specialty Choice, Progr...
https://doi.org/10.1007/s40596-022-01611-6 10.17226/13400 10.1007/s40596-019-01033-x 10.1007/s40596-021-01413-2 10.1097/JGP.0b013e31820dcbcc 10.1097/ACM.0000000000002468 10.1176/appi.ap.28.3.240
Academic Psychiatry : the Journal of the American Associa... Agapoff JR, Maixner S et. al.

Mar 9th, 2022 - This study explored factors influencing a physician's choice to pursue geriatric psychiatry fellowship training from fellow and program director perspectives to improve recruitment into this critical need specialty. Questionnaires were sent to the...

Perspectives on the Clinical Use of Pharmacogenetic Testing in Late-Life Mental Healthc...
https://doi.org/10.1016/j.jagp.2021.09.013
The American Journal of Geriatric Psychiatry : Official J... Bousman CA, Oomen A et. al.

Nov 7th, 2021 - To assess perspectives on pharmacogenetic (PGx) testing among members of the American Association of Geriatric Psychiatry (AAGP). Cross-sectional survey. Members of the AAGP. Anonymous web-based survey consisting of 41 items covering experiences, ...

The AAGP Scholars Program: Predictors of Pursuing Geriatric Psychiatry Fellowship Train...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391076
The American Journal of Geriatric Psychiatry : Official J... Conroy ML, Yarns BC et. al.

Aug 24th, 2020 - The American Association for Geriatric Psychiatry (AAGP) Scholars Program was developed to recruit trainees into geriatric psychiatry fellowships and is considered a pipeline for fellowship recruitment. Nonetheless, the number of trainees entering...

The COVID-19 AAGP Online Trainee Curriculum: Development and Method of Initial Evaluation.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293448
The American Journal of Geriatric Psychiatry : Official J... Conroy ML, Garcia-Pittman EC et. al.

Jul 7th, 2020 - One effect of the COVID-19 pandemic is the disruption of in-person clinical experiences within geriatric psychiatry residency education. Online resources for trainees are needed to fill resultant gaps. The American Association of Geriatric Psychia...

The American Association for Geriatric Psychiatry's Trainee Programs: Participant Chara...
https://doi.org/10.1016/j.jagp.2020.03.002
The American Journal of Geriatric Psychiatry : Official J... Wilkins KM, Conroy ML et. al.

Apr 10th, 2020 - The number of physicians trained in geriatric psychiatry is dwindling. The American Association for Geriatric Psychiatry (AAGP) developed novel educational programs designed to foster interest in the field. The objective of this study was to compa...

see more →

News  23 results

Atypical Anxiety an Intervention Target in Parkinson's?
https://www.medscape.com/viewarticle/971733

Apr 6th, 2022 - Atypical anxiety in adults with Parkinson's disease ranged from 15% to 51% in a systematic review of 60 studies. Dr Nadeeka Dissanayaka Anxiety is common in Parkinson's disease (PD) and has been shown to increase functional disability and decrease...

Positive Long-term Results for Tardive Dyskinesia Drug
https://www.medscape.com/viewarticle/894722

Apr 3rd, 2018 - HONOLULU, Hawaii — Valbenazine (Ingrezza, Neurocrine Biosciences) is safe and effective over the long term as a treatment for tardive dyskinesia (TD) in older patients, new research suggests. Dr Martha Sajatovic Further results from the KINECT 3 a...

Schizophrenia Drug Reduces Alzheimer's-Related Agitation
https://www.staging.medscape.com/viewarticle/894134

Mar 19th, 2018 - HONOLULU, Hawaii — The atypical antipsychotic brexpiprazole (Rexulti, Otsuka and Lundbeck) is safe and effective for treating agitation in patients with dementia related to Alzheimer's disease (AD) — at least at its highest dose, new research sugg...

Schizophrenia Drug Reduces Alzheimer's-Related Agitation
https://www.medscape.com/viewarticle/894134

Mar 19th, 2018 - HONOLULU, Hawaii — The atypical antipsychotic brexpiprazole (Rexulti, Otsuka and Lundbeck) is safe and effective for treating agitation in patients with dementia related to Alzheimer's disease (AD) — at least at its highest dose, new research sugg...

Ageism in Medicine Must Stop, Experts Say
https://www.medscape.com/viewarticle/894078

Mar 19th, 2018 - HONOLULU, Hawaii — Ageism is not only prevalent in society, it's also widespread in medical education and in the clinic. This situation, say leading experts, results in substandard care and poor outcomes for older patients. A symposium here at the...

see more →